Team:Groningen/Template/MODULE/project/MBD/results

From 2014.igem.org

(Difference between revisions)

Latest revision as of 02:58, 18 October 2014

Results

Based on the simulation data we compared our design outcome with the design requirements.

Performance table

Design	Tnisin	TAiiA	TDspB	Ease of manufacturing	Rating
1	0.4	0.5	0.5	Too easy	1
2	0.4	0.5	0.5	Moderate	3
3	0.3	0.3	0.3	Moderate	2
4	0.2	0.3	0.3	Moderate	1
5	1.9	2.2	2.4	Difficult	5
6	1.9	2.3	2.4	Difficult	4

@@ Line 15: / Line 15: @@
 <div class="hspacer">&nbsp;</div>
 <!-- TITLE SNIPPET END-->
+<!-- PARAGRAPH SNIPPET START-->
+<div class="text">
+Based on the simulation data we compared our design outcome with the design requirements.
+</div>
+<div class="hspacer">&nbsp;</div>
+<!-- PARAGRAPH SNIPPET END-->
+<!-- PARAGRAPH SNIPPET START-->
+<div class="text">
+Performance table
+</div>
+<div class="hspacer">&nbsp;</div>
+<!-- PARAGRAPH SNIPPET END-->
 <!-- TABLE SNIPPET OPTIONAL START-->
@@ Line 20: / Line 37: @@
 <tr>
-<th>Design</th><th>Tnisin</th><th>TAiiA</th><th>TDspB</th><th>Rating</th>
+<th>Design</th><th>Tnisin</th><th>TAiiA</th><th>TDspB</th><th>Ease of manufacturing</th><th>Rating</th>
 </tr>
 <tr>
-<td>1</td><td>3 h</td><td>something</td><td>something</td><td>something</td>
+<td>1</td><td>0.4</td><td>0.5</td><td>0.5</td><td>Too easy</td><td>1</td>
 </tr>
 <tr>
-<td>2</td><td>?</td><td>After being applied to the wound. Amount of time for reaching the inhibitory concentrations of nisin, DspB and AiiA to pass the bottom membrane and into the wound. </td>
+<td>2</td><td>0.4</td><td>0.5</td><td>0.5</td><td>Moderate</td><td>3</td>
 </tr>
 <tr>
-<td>3 </td><td>tbd</td><td>In what quantity does S. aureus need to be detected?</td>
+<td>3</td><td>0.3</td><td>0.3</td><td>0.3</td><td>Moderate</td><td>2</td>
 </tr>
 <tr>
-<td>4</td><td>tbd</td><td>In what quantity does P. aeruginosa need to be detected?</td>
+<td>4</td><td>0.2</td><td>0.3</td><td>0.3</td><td>Moderate</td><td>1</td>
 </tr>
 <tr>
-<td>5</td><td>2-16 ng/µL</td><td>This concentration can be used for both MRSA and VRE. Source: Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity ……. Brumfitt, Salton, Hamilton-Miller.</td>
+<td>5</td><td>1.9</td><td>2.2</td><td>2.4</td><td>Difficult</td><td>5</td>
 </tr>
 <tr>
-<td>6</td><td>tbd</td><td>How much is needed to inhibit growth of PA/SA?</td>
+<td>6</td><td>1.9</td><td>2.3</td><td>2.4</td><td>Difficult</td><td>4</td>
 </tr>